Researchers evaluated an electronic health record-based intervention that identified patients with metastatic cancer for a multipronged approach to their in-hospital care.

Researchers studied the progression-free and overall survival rates of patients with advanced melanoma after cessation of immune checkpoint inhibitor therapy.

A prognostic index can be used to identify patients with estrogen receptor (ER)-positive, HER2-negative early breast cancer who can safely forgo adjuvant chemotherapy as well as patients who require ...

Radiotherapy is a cornerstone of prostate cancer treatment. Moderately hypofractionated radiotherapy (MHFRT) is advancing this care by delivering higher radiation doses per fraction over fewer ...

Surufatinib did not provide an overall survival (OS) benefit over placebo in patients with advanced neuroendocrine tumors (NETs) enrolled in a pair of phase 3 trials. However, there was a high ...

The cohorts had similar proportions of females (39% and 40%), non-White (6% vs 4%) and Hispanic (4% vs 1%) patients, those with newly-diagnosed disease (42% for both), and months post MM diagnosis ...

Among the included patients, 1359 (43.8%) had uncontrolled pain, and 1044 (33.6%) experienced high-impact pain. Patients with uncontrolled pain were nearly 10 times more likely to develop OUD ...

HealthDay News — Rates of colorectal cancer detection through colonoscopy screening are similar for adults aged 45 to 49 years and 50 to 54 years, according to a research letter published online ...

Combination treatment with zanubrutinib and venetoclax has elicited durable responses in patients with treatment-naïve chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) and ...

M. Frank Rachel, Author at Oncology Nurse AdvisorM. Frank Rachel ...

Weiss Rachel, Author at Oncology Nurse AdvisorWeiss Rachel ...

Edward Bittner, Author at Oncology Nurse AdvisorEdward Bittner ...